Որոնման արդյունքները - David N. Cook
- Ցուցադրվում են 1 - 7 արդյունքները 7
-
1
-
2
<i>Listeria</i>-based cancer vaccines that segregate immunogenicity from toxicity Dirk G. Brockstedt, Martin Giedlin, Meredith L. Leong, Keith S. Bahjat, Yi Qin Gao, William Luckett, Weiqun Liu, David N. Cook, Daniel A. Portnoy, Thomas W. Dubensky
Հրապարակվել է 2004Artigo -
3
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>Infection Sahil Khanna, Darrell S. Pardi, Colleen Kelly, Colleen S. Kraft, Tanvi Dhere, Matthew R. Henn, Mary-Jane Lombardo, Marin Vulić, Toshiro K. Ohsumi, Jonathan Winkler, Christina Pindar, Barbara McGovern, Roger J. Pomerantz, John Auniņš, David N. Cook, Elizabeth Hohmann
Հրապարակվել է 2016Artigo -
4
Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics Julie E. Button, Chloe Autran, Abigail L. Reens, Casey M. Cosetta, Steven Smriga, M. Ericson, Jessica V. Pierce, David N. Cook, Martin L. Lee, Adam K. Sun, Amin M. Alousi, Andrew Y. Koh, David J. Rechtman, Robert R. Jenq, Gregory J. McKenzie
Հրապարակվել է 2022Artigo -
5
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity Dirk G. Brockstedt, Keith S. Bahjat, Martin Giedlin, Wei Liu, Mark K Leong, William Luckett, Yi Gao, Pamela Schnupf, Dilnawaz Kapadia, Grace Castro, Jie-Hui Lim, Adam Sampson-Johannes, Anat A. Herskovits, Adonis Stassinopoulos, H. G. Archie Bouwer, J Hearst, Daniel A. Portnoy, David N. Cook, Thomas W. Dubensky
Հրապարակվել է 2005Artigo -
6
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial Barbara McGovern, Christopher B. Ford, Matthew R. Henn, Darrell S. Pardi, Sahil Khanna, Elizabeth Hohmann, Edward J. O’Brien, Christopher A. Desjardins, Patricia Bernardo, Jennifer R. Wortman, Mary-Jane Lombardo, Kevin Litcofsky, Jonathan Winkler, Christopher McChalicher, Sunny S. Li, Amelia D. Tomlinson, Madhumitha Nandakumar, David N. Cook, Roger J. Pomerantz, John Auniņš, Michele Trucksis
Հրապարակվել է 2020Artigo -
7
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis Matthew R. Henn, Edward J. O’Brien, Liyang Diao, Brian G. Feagan, William J. Sandborn, Curtis Huttenhower, Jennifer R. Wortman, Barbara McGovern, Sherry Wang‐Weigand, David I. Lichter, Meghan Chafee, Christopher B. Ford, Patricia Bernardo, Peng Zhao, Sheri L. Simmons, Amelia D. Tomlinson, David N. Cook, Roger J. Pomerantz, Bharat Misra, John Auniņš, Michele Trucksis
Հրապարակվել է 2020Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Biology
Microbiology
Genetics
Bacteria
Bioinformatics
Gene
Immunology
Medicine
Microbiome
Antibiotics
Clostridium difficile
Environmental health
Gastroenterology
Gut flora
Immune system
Immunity
Internal medicine
Listeria monocytogenes
Population
Virology
Virulence
Adverse effect
Alternative medicine
Amino acid
Antigen
Attenuated vaccine
Bifidobacterium
Bifidobacterium longum
Biochemistry
Butyrate